Study to Evaluate the Genetic, Epigenetic, and Proteomic Expression in Latino Participants With and Without HIV Coinfection Receiving Treatment for Hepatitis C.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Pharmacogenomic; Therapeutic Use
Most Recent Events
- 24 Sep 2019 Biomarkers information updated
- 20 Mar 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Apr 2012 Planned number of patients changed from 100 to 150 as reported by ClinicalTrials.gov.